Finlandia - fiński - Fimea (Suomen lääkevirasto)

berlin-chemie ag - dapoxetine hydrochloride - tabletti, kalvopäällysteinen - 60 mg - dapoksetiini

Finlandia - fiński - Fimea (Suomen lääkevirasto)

orpha-devel handels und vertriebs gmbh - midazolami maleas - tabletti, kalvopäällysteinen - 15 mg - midatsolaami

Unia Europejska - fiński - EMA (European Medicines Agency)

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Unia Europejska - fiński - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiset aineet - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Unia Europejska - fiński - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - rintojen kasvaimet - endokriinihoito - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Unia Europejska - fiński - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - psoriasis - immunosuppressantit - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Finlandia - fiński - Fimea (Suomen lääkevirasto)

pfizer oy pfizer oy - triazolamum - tabletti - 0.125 mg - triatsolaami

Finlandia - fiński - Fimea (Suomen lääkevirasto)

teva sweden ab - clarithromycinum - tabletti, kalvopäällysteinen - 250 mg - klaritromysiini

Finlandia - fiński - Fimea (Suomen lääkevirasto)

teva sweden ab - clarithromycinum - tabletti, kalvopäällysteinen - 500 mg - klaritromysiini

Unia Europejska - fiński - EMA (European Medicines Agency)

pfizer europe ma eeig - temsirolimuusin - carcinoma, renal cell; lymphoma, mantle-cell - antineoplastiset aineet - munuaisten-cell carcinomatorisel on tarkoitettu käytettäväksi ensilinjan hoitoon aikuispotilaille, joilla on pitkälle edennyt munuaisten-cell carcinoma (rcc), joka on vähintään kolme-kuusi ennustavia riskitekijöitä. mantle-cell lymphomatorisel on tarkoitettu aikuisille potilaille, joilla on uusiutunut ja / tai vaikeahoitoinen vaipan-solun lymfooman (mcl).